ZarowitzBJMumaBCogganPDavisGBarkleyGL. Managing the pharmaceutical industry—health system interface. Ann Pharmacother2001;35: 1661–8.
2.
FergusonRPRhimEBelizaireWEgedelLCarterKLansdaleT. Encounters with pharmaceutical sales representatives among practicing internists. Am J Med1999;107: 149–52.
3.
PeayMYPeayEY. The role of commercial sources in the adoption of a new drug. Soc Sci Med1988;26: 1183–9.
4.
AndaleebSSTallmanRP. Physician attitudes toward pharmaceutical sales representatives. Health Care Manage Rev1995;20: 68–76.
5.
StolbergSGGerthJ. High-tech stealth being used to sway doctor prescriptions. The New York Times2000;16 Nov:A2,25.
6.
BlakeRLJr.EarlyEK. Patients' attitudes about gifts to physicians from pharmaceutical companies. J Am Board Fam Pract1995;8: 457–64.
7.
McKinneyWPRichEC. Gifts to physicians from the pharmaceutical industry (letter). JAMA2000;284:2655.
8.
AvornJChenMHartleyR. Scientific versus commercial sources of influences on the prescribing behavior of physicians. Am J Med1982;73: 4–8.
9.
GibbonsRVLandryFJBlouchDLJonesDLWilliamsFKLuceyCRA comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med1998;13: 151–4.
10.
WazanaA. Physicians and the pharmaceutical industry. Is a gift ever just a gift?JAMA1999;283: 373–80.
11.
RothmanDJ. Medical professionalism — Focusing on the real issues. N Engl J Med2000;342: 1284–6.
12.
Gifts to physicians from industry. JAMA1991;265:501.
13.
Physicians and the pharmaceutical industry. American College of Physicians. Ann Intern Med1990;112: 624–6.
14.
McCormickBBTomlinsonGBrill-EdwardsPDetskyAS. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA2001;286: 1994–9.
15.
WiebeC. Drug representatives and residents: Dangerous liaison?ACP Observer1995;15(Sept):8–9.
16.
SteinmanMA. MSJAMA: Gifts to physicians in the consumer marketing era. JAMA2000;284:2243.
